Our ability to develop, manufacture and distribute therapeutics has changed dramatically with covid, Brexit and the increasingly volatile geopolitical landscape. That has created numerous challenges for life sciences companies in the risks they face, in securing supply chains and in managing regulatory affairs. But periods of great change bring opportunities too as new products and approaches emerge and markets evolve.
https://www.workcast.com/register?cpak=8677848293806859&referrer=nscom